Physician-Designed Protocol
LongevityStack Protocol
Comprehensive anti-aging stack targeting NAD+ decline, mitochondrial dysfunction, cellular senescence, and age-related inflammation. Based on Sinclair/Attia-style protocols.
Who This Protocol Is For
Age 35+
NAD+ begins significant decline in mid-30s. Early intervention window.
Metabolically Healthy
Baseline labs clean — ready to optimize rather than correct dysfunction.
Long-Term Focused
Goal is healthspan extension — cognitive and physical longevity over decades.
Target Outcomes
NAD+
Declining with age
Youthful levels
50-100% increase
4-8 weeks
IGF-1
Variable
Optimal range
Based on goals
Ongoing
hs-CRP
>1.0 mg/L
<0.5 mg/L
Meaningful reduction
8-12 weeks
Biological Age
Chronological
Younger than chrono
2-5 years reversal
12 months